Literature DB >> 1620291

Sustained release of nerve growth factor from biodegradable polymer microspheres.

P J Camarata1, R Suryanarayanan, D A Turner, R G Parker, T J Ebner.   

Abstract

Although grafted adrenal medullary tissue to the striatum has been used both experimentally and clinically in parkinsonism, there is a definite need to augment long-term survival. Infusion of nerve growth factor (NGF) or implantation of NGF-rich tissue into the area of the graft prolongs survival and induces differentiation into neural-like cells. To provide for prolonged, site-specific delivery of this growth factor to the grafted tissue in a convenient manner, we fabricated biodegradable polymer microspheres of poly(L-lactide)co-glycolide (70:30) containing NGF. Biologically active NGF was released from the microspheres, as assayed by neurite outgrowth in a dorsal root ganglion tissue culture system. Anti-NGF could block this outgrowth. An enzyme-linked immunosorbent assay detected NGF still being released in vitro for longer than 5 weeks. In vivo immunohistochemical studies showed release over a 4.5-week period. This technique should prove useful for incorporating NGF and other growth factors into polymers and delivering proteins and other macromolecules intracerebrally over a prolonged time period. These growth factor-containing polymer microspheres can be used in work aimed at prolonging graft survival, treating experimental Alzheimer's disease, and augmenting peripheral nerve regeneration.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1620291     DOI: 10.1227/00006123-199203000-00001

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  11 in total

Review 1.  Inductive tissue engineering with protein and DNA-releasing scaffolds.

Authors:  David M Salvay; Lonnie D Shea
Journal:  Mol Biosyst       Date:  2005-11-25

2.  In vitro and in vivo release of nerve growth factor from biodegradable poly-lactic-co-glycolic-acid microspheres.

Authors:  Ralph de Boer; Andrew M Knight; Robert J Spinner; Martijn J A Malessy; Michael J Yaszemski; Anthony J Windebank
Journal:  J Biomed Mater Res A       Date:  2010-09-28       Impact factor: 4.396

Review 3.  Distribution of drugs following controlled delivery to the brain interstitium.

Authors:  M Mak; L Fung; J F Strasser; W M Saltzman
Journal:  J Neurooncol       Date:  1995-11       Impact factor: 4.130

Review 4.  Localized delivery of proteins in the brain: can transport be customized?

Authors:  M F Haller; W M Saltzman
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

5.  Peptide acylation by poly(alpha-hydroxy esters).

Authors:  Andrea Lucke; Josef Kiermaier; Achim Göpferich
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

6.  Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems.

Authors:  W M Saltzman; M W Mak; M J Mahoney; E T Duenas; J L Cleland
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

7.  Why does PEG 400 co-encapsulation improve NGF stability and release from PLGA biodegradable microspheres?

Authors:  J M Péan; F Boury; M C Venier-Julienne; P Menei; J E Proust; J P Benoit
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

Review 8.  Therapeutic potential of nerve growth factors in Parkinson's disease.

Authors:  T J Collier; C E Sortwell
Journal:  Drugs Aging       Date:  1999-04       Impact factor: 3.923

9.  Skeletal myogenic differentiation of urine-derived stem cells and angiogenesis using microbeads loaded with growth factors.

Authors:  Guihua Liu; Rajesh A Pareta; Rongpei Wu; Yingai Shi; Xiaobo Zhou; Hong Liu; Chunhua Deng; Xiangzhou Sun; Anthony Atala; Emmanuel C Opara; Yuanyuan Zhang
Journal:  Biomaterials       Date:  2012-11-06       Impact factor: 12.479

Review 10.  Urine-derived stem cells for potential use in bladder repair.

Authors:  Danian Qin; Ting Long; Junhong Deng; Yuanyuan Zhang
Journal:  Stem Cell Res Ther       Date:  2014-05-28       Impact factor: 6.832

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.